• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS INTEGRA CREATININE PLUS VER.2 ASSAY; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS INTEGRA CREATININE PLUS VER.2 ASSAY; ENZYMATIC METHOD, CREATININE Back to Search Results
Catalog Number 03263991190
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/13/2024
Event Type  malfunction  
Event Description
We received an allegation about discrepant results for 5 patients' samples tested with creatinine gen.2 (crep2) assay on a cobas integra 400 plus analyzer.Sample 1: initial result: 100.5 umol/l.Repeat result: 62.3 umol/l.Sample 2: initial result: 108.1 umol/l.Repeat result: 62.6 umol/l.Sample 3: initial result: 141.0 umol/l.Repeat result: 95.7 umol/l.Sample 4 and sample 5 were tested on (b)(6) 2024: sample 4: initial result: 115.0 umol/l.Repeat result: 63.6 umol/l.Sample 5: initial result: 111.1 umol/l.Repeat result: 88.6 umol/l.The initial results were reported to the client who compared them to results they had from another laboratory.The client questioned the results as they did not match with the other laboratory's results.The samples were then repeated.The repeat results were deemed to be correct.
 
Manufacturer Narrative
The cobas integra 400 plus analyzer serial number was (b)(6).Qc within the assigned ranges on the day of the event.The customer stated that they replaced the probes.The investigation is ongoing.
 
Manufacturer Narrative
The customer alleged discrepant results for an additional patient sample tested on (b)(6)2024: sample 6: initial result: 115.0 mol/l.Repeat result: 63.6 mol/l.A general reagent issue can be excluded because calibration and qc were acceptable.The extra wash cycles were correctly installed.The required data for the investigation was requested but not provided.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS INTEGRA CREATININE PLUS VER.2 ASSAY
Type of Device
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE INSTRUMENT CENTER AG TEGIMENTA
forrenstrasse
rotkreuz 6343
WZ   6343
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250-0457
MDR Report Key18861210
MDR Text Key337189738
Report Number1823260-2024-00701
Device Sequence Number1
Product Code JFY
UDI-Device Identifier04015630919215
UDI-Public04015630919215
Combination Product (y/n)Y
Reporter Country CodeSF
PMA/PMN Number
K951595
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/03/2024
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received03/07/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number03263991190
Device Lot Number74766501
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/11/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-